Universal Biosensors (ASX:UBI) 3-Year Revenue Growth Rate : 19.90% (As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors 3-Year Revenue Growth Rate?

Universal Biosensors's Revenue per Share for the three months ended in Sep. 2024 was A$0.01.

During the past 12 months, Universal Biosensors's average Revenue per Share Growth Rate was 16.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -32.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Universal Biosensors was 133.80% per year. The lowest was -56.20% per year. And the median was 6.80% per year.

Competitive Comparison of Universal Biosensors's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Universal Biosensors's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Biosensors's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's 3-Year Revenue Growth Rate falls into.

Universal Biosensors 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Universal Biosensors (ASX:UBI) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Universal Biosensors 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Biosensors Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Corporate Avenue, Rowville, VIC, AUS, 3178

Website

https://www.universalbiosensors.com

Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines